Market Report, "Hungary Pharmaceuticals & Healthcare Report Q1 2014", Published
BMI View: We do not envisage much improvement in terms of Hungary's operating environment for pharmaceutical manufacturers heading into 2014. Despite the volume demand supported by population ageing and epidemiological factors, continued downward pressure on prescription prices remains a major issue.
View full press release